Long-read sequencing technologies have fundamentally transformed genomics by enabling the interrogation of complex genomes with a resolution previously unattainable with short-read methods. By reading continuous DNA fragments tens to hundreds of thousands of base pairs in length, these techniques empower scientists to resolve repetitive regions, detect large structural variants, and phase haplotypes with high confidence. This article reviews the latest emerging techniques in long-read sequencing, examining the technological innovations, computational advances, and integrative approaches that are expanding the frontiers of genome analysis.

Recent Advances in Long-Read Sequencing Platforms

The past few years have witnessed remarkable progress in the chemistry, hardware, and software underlying long-read sequencing. Key manufacturers have introduced new reagents, flow cells, and imaging systems that substantially boost read length, base‑calling accuracy, and overall throughput. For instance, the latest generation of single‑molecule real‑time (SMRT) sequencing from Pacific Biosciences (PacBio) now routinely achieves median read lengths exceeding 15 kilobases, while Oxford Nanopore Technologies (ONT) has demonstrated reads surpassing 2 megabases. These extended reads are critical for spanning complex genomic features such as centromeres, telomeres, and segmental duplications, which often resist assembly from short reads alone.

Enhancements in library preparation protocols further contribute to data quality. Methods that minimize DNA damage, reduce fragmentation, and optimize molecular loading have been shown to increase both the yield and length of long reads. For PacBio, the adoption of the “HiFi” (high‑fidelity) workflow uses circular consensus sequencing (CCS) to generate a single, highly accurate consensus read from multiple passes of the same circularized template molecule. This approach dramatically reduces error rates from >10% in raw long reads to <0.1%, producing reads that are both long and accurate. Similarly, ONT has improved its library chemistry—such as the ligation sequencing kit and rapid sequencing kit—to reduce chimeric artifacts and improve pass‑through rates on the pore.

On the computational side, base‑calling algorithms have evolved from simple hidden Markov models to deep‑neural‑network architectures (e.g., Guppy, Bonito, and the recently released Dorado). These models are trained on large datasets to correct systematic errors, such as homopolymer length inaccuracies, and to call modified bases directly from the raw signal. The result is a dramatic improvement in consensus accuracy without sacrificing read length. Emerging techniques also leverage machine learning to filter out low‑quality reads, detect structural variant breakpoints, and even predict DNA methylation states from the same sequencing run.

Key Technologies Driving Innovation

PacBio HiFi Sequencing

PacBio’s HiFi sequencing, commercially delivered on the Sequel IIe and Revio systems, represents a paradigm shift in long‑read accuracy. By circularizing each DNA molecule and sequencing it multiple times (typically 15–30 passes), the technology produces a consensus read that achieves >99.9% accuracy even across repetitive regions. Typical HiFi read lengths range from 10 to 25 kilobases, though protocols can be tuned to produce longer fragments at the expense of throughput. This combination of length and accuracy makes HiFi reads ideal for de novo genome assembly, where they can produce contiguous assemblies with median contig N50 values exceeding 50 megabases in highly polymorphic or repeat‑rich genomes.

Recent innovations in PacBio’s chemistry—such as improved polymerase enzymes that incorporate nucleotides faster and with higher fidelity, and refined signal‑processing optics that reduce noise—have placed further upward pressure on both throughput and quality. The Revio system, introduced in 2022, uses a new SMRT Cell capable of generating up to 130 gigabases of HiFi data per cell, making whole‑human‑genome HiFi sequencing a reality within a single flow cell run. This has opened the door to population‑scale studies of structural variation and rare disease genomics, where high‑quality, long‑range information is increasingly recognized as essential.

Oxford Nanopore Technologies

Oxford Nanopore’s platforms (MinION, GridION, PromethION) offer a distinctly complementary approach: real‑time sequencing of native, unmodified DNA or RNA strands as they pass through a protein nanopore. The technology’s hallmark is its ability to produce ultra‑long reads, with some experiments yielding molecules exceeding 2 million base pairs. These reads are instrumental for spanning highly repetitive regions, such as centromeric satellites and ribosomal DNA arrays, and for resolving complex structural variants that are invisible to short‑read approaches.

Nanopore sequencing has seen rapid improvements in per‑base accuracy through better pore configurations, optimized motor proteins, and sophisticated base‑calling algorithms. The latest R10.4.1 pores, combined with the high‑accuracy base‑calling models in the Dorado software, routinely achieve median read accuracies above 99.5% (Q20+) at moderate read lengths. Furthermore, the ability to detect modified bases—such as 5‑methylcytosine, 5‑hydroxymethylcytosine, and 6‑methyladenine—from the same electrical signal without additional sample preparation has made Nanopore a powerful tool for integrated genetic and epigenetic analysis.

Emerging techniques in nanopore technology include “Read Until” approaches that allow real‑time target selection, where the sequencing run can be dynamically steered to enrich for regions of interest. Additionally, adapters and barcoding schemes now enable high‑throughput multiplexing of hundreds of samples per flow cell, greatly reducing per‑sample costs and making long‑read sequencing accessible for clinical and field‑based applications.

Emerging Techniques and Future Directions

Hybrid Assembly Approaches

While both PacBio HiFi and ONT reads can independently produce high‑quality assemblies, many researchers are adopting hybrid strategies that combine the best of both platforms. The most common approach uses HiFi reads (high accuracy, moderate length) as the back‑bone for contig formation, then scaffolds and fills gaps with ultra‑long Nanopore reads. Tools like shasta, canu, hifiasm, and verkko have been developed to handle these hybrid input sets, often producing assemblies that are both contiguous and highly accurate. Recent work on the complete human genome (the Telomere‑to‑Telomere consortium) relied heavily on such hybrid strategies to close previously unresolvable gaps in centromeres, segmental duplications, and ribosomal DNA arrays.

Computational Algorithms for Error Correction and Assembly

The error profiles of long reads differ fundamentally from short reads, necessitating specialized algorithms. New error‑correction tools, such as medaka (for ONT) and pbmm2 / ccs (for PacBio), have been refined to leverage the high‑quality regions of each read to improve the consensus across the entire dataset. For assembly, graph‑based approaches that represent the entire read set as a string graph or a de Bruijn graph have been adapted for long reads. The miniasm and flye assemblers, for example, produce draft assemblies from uncorrected reads that can then be polished with HiFi data. Deep learning models are increasingly used to resolve ambiguous paths through the assembly graph, particularly in regions of high heterozygosity or repetitive content.

Beyond assembly, computational pipelines for detecting structural variants (SVs) from long reads have matured. Callers like Sniffles2, Picky, and cuteSV employ breakpoint‑spanning read clustering and sequence alignment to identify deletions, duplications, inversions, translocations, and mobile element insertions. These tools now achieve sensitivity >95% for SVs >50 bp, a dramatic improvement over short‑read‑based SV calling, which often misses events in repetitive regions.

Integration with Epigenomic Analysis

One of the most exciting emerging techniques is the simultaneous interrogation of genome sequence and epigenome from a single long‑read dataset. Nanopore’s direct detection of DNA modifications has matured to a point where quantitative methylation‑level estimation is possible at single‑base resolution. HiFi sequencing, while not directly detecting modifications in the raw signal, can be combined with bisulfite conversion or enzymatic methylation‑sensitive approaches to provide long‑read epigenomic profiles. This integration is proving invaluable in cancer genomics, where large‑scale structural variations are often accompanied by widespread epigenetic reprogramming. Long‑read approaches can now phase both genetic and epigenetic changes along individual haplotypes, revealing how methylation patterns are propagated and altered across structural rearrangements.

Direct RNA Sequencing and Transcriptomics

Oxford Nanopore also offers direct RNA sequencing (DRS), which sequences native RNA molecules without reverse transcription or amplification. This technique preserves RNA modifications (e.g., m6A, pseudouridine) and provides full‑length transcript isoform information. Emerging improvements include higher throughput, better pore sensitivity for RNA, and base‑calling models trained specifically for RNA modification detection. Direct RNA sequencing is opening new windows into alternative splicing, poly‑A tail length analysis, and the functional impact of RNA editing in complex transcriptomes.

Applications in Complex Genome Analysis

Complete Genome Assembly and T2T Projects

The Telomere‑to‑Telomere (T2T) consortium’s achievement of the first truly complete human genome sequence in 2022 is a landmark demonstration of long‑read sequencing’s power. By combining >30× coverage of HiFi reads and >70× coverage of ultra‑long Nanopore reads (and using manual curation with optical maps), the team resolved every gap, including the challenging Y chromosome. Similar efforts are now underway for many other species, from crop plants to endangered mammals. Emerging techniques in long‑read metagenomics are also enabling the reconstruction of complete, circular genomes from previously uncharacterized microbes in complex environmental samples.

Structural Variant Discovery in Human Disease

Long‑read sequencing has become the gold standard for discovering and characterizing structural variants (SVs) in human genomes. Studies have cataloged tens of thousands of SVs per genome, many of which are missed or poorly resolved by short reads. Emerging techniques now allow precise breakpoint mapping even in segmental duplications and low‑complexity repeats. In clinical contexts, long‑read sequencing is being used to solve “genomic mysteries” in patients with rare diseases that have eluded standard exome or genome sequencing. The ability to fully phase variants and detect compound heterozygosity or de novo structural events is driving diagnostic yields upward.

Population Genetics and Evolutionary Studies

High‑quality reference genomes generated from long‑read assemblies are enabling more accurate comparative genomic analyses across populations and species. For example, in great apes, long‑read sequencing has revealed lineage‑specific expansions of gene families and retrotransposons that are invisible to short‑read approaches. Similarly, in plants with large, repeat‑rich genomes (e.g., wheat, maize, conifers), long‑read sequencing has allowed the first comprehensive surveys of structural variation associated with domestication and adaptation. Emerging techniques such as “pan‑genome” studies—where multiple long‑read assemblies from different individuals are compared directly—are providing a more complete picture of genomic diversity within a species.

Cancer Genomics and Liquid Biopsy

Long‑read techniques are increasingly applied to cancer genomes, where massive rearrangements, copy number changes, and epigenetic alterations are common. Studies using long‑reads have identified previously hidden gene fusions and extrachromosomal circular DNA (ecDNA) that drive oncogenesis. In liquid biopsy, nanopore sequencing of circulating cell‑free DNA (cfDNA) can detect tumor‑specific structural variants and methylation patterns with high sensitivity. Emerging methods for targeted long‑read sequencing in liquid biopsy are promising for non‑invasive cancer monitoring and early detection.

Challenges and Limitations

Despite these advances, long‑read sequencing faces several persistent challenges. Per‑base accuracy, while improved, still lags behind short‑read platforms (Illumina’s <0.1% error rate) for certain contexts, particularly in homopolymer tracts and highly repetitive regions. Base‑calling errors, especially at the individual‑read level, can confound single‑molecule applications such as phasing or methylation calling at low depth. Throughput and cost remain barriers for large‑scale population studies; although costs are dropping, a high‑depth long‑read human genome still costs upwards of $1,000–$3,000 for HiFi or Nanopore, compared to ~$200 for a standard short‑read genome.

Library preparation for ultra‑long reads requires high‑molecular‑weight DNA, which can be difficult to obtain from formalin‑fixed, paraffin‑embedded (FFPE) tissue or degraded forensic samples. Shearing, fragmentation, and DNA damage during extraction reduce the fraction of truly long molecules. Emerging techniques in gentle DNA extraction (e.g., using agarose plugs or magnetic bead‑based protocols) are mitigating this issue but add complexity.

Computational demands are also non‑trivial. The large volume of raw signal data from nanopore sequencers (or the large BAM files from HiFi) requires substantial storage and processing power. Real‑time base‑calling, while possible on a GPU, consumes significant electrical and computational resources. Moreover, de novo assembly of large genomes from long reads remains a computationally heavy task, although recent improvements in algorithms have reduced both runtime and memory footprint.

Outlook and Future Directions

The next five years promise further breakthroughs in long‑read sequencing. On the hardware side, new solid‑state nanopores and integrated circuit sensors could drastically increase throughput and reduce costs. Companies such as PacBio are developing benchtop systems that bring HiFi to the clinical laboratory, while ONT continues to miniaturize its devices for field applications. On the chemistry front, the ability to sequence longer templates (>>2 Mb) without sacrificing accuracy is being actively pursued. Concurrently, novel base‑calling models leveraging transformer architectures and self‑supervised learning are expected to push raw read accuracy beyond Q30 (99.9%) for nanopore.

Integration with spatial transcriptomics and single‑cell genomics is another emerging frontier. Long‑read sequencing of barcoded single‑cell cDNA or gDNA can provide full‑length isoform information and phased variant calls at cellular resolution. Early work in this area has shown that hybrid approaches combining long‑read and short‑read single‑cell data can reveal cell‑type‑specific alternative splicing and mutations that are missed by short‑reads alone.

Finally, the shift toward “pangenomic” reference genomes, where many high‑quality long‑read assemblies from different individuals are jointly analyzed, will fundamentally alter how we interpret human genetic variation. The ability to detect rare, large SVs and to study the impact of repeat expansions on gene regulation and disease will become routine as these techniques mature. Emerging long‑read sequencing techniques are not merely improving existing genomic analyses; they are enabling entirely new forms of biological inquiry, from the complete orchestration of epigenetic marks across megabase‑scale regions to the real‑time tracking of viral quasispecies in an infected host.

Conclusion

Emerging techniques in long‑read sequencing are rapidly transforming our capacity to analyze complex genomes. Through advances in chemistry, hardware, and computation, technologies such as PacBio HiFi and Oxford Nanopore are now delivering accurate, ultra‑long reads that can span the most recalcitrant genomic features—repetitive regions, centromeres, and large structural variants—with unprecedented fidelity. Hybrid approaches and integration with epigenomic analysis are further expanding the scope of information obtained from a single experiment. While challenges remain in cost, throughput, and computational burden, the trajectory is clear: long‑read sequencing will become the standard for de novo assembly, structural variant discovery, and comprehensive genome characterization in both research and clinical settings. As these techniques continue to evolve, they promise to unlock deeper insights into genetic structure, function, and diversity that will drive advances in medicine, agriculture, and evolutionary biology.